Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
EVG.L Share News (EVG)
EVG Share
Price
EVG Share
News
EVG Share
Chat
EVG Share
Trades
EVG
Live RNS
EVG Share
Charts
EVG Broker
Ratings
EVG Directors
Deals
EVG Financial
Diary
EVG
Fundamentals
EVG Short
Positions
EVG
Media
EVG Company
Research
EVG Company
Timeline
- There is currently no data for EVG
Evolution ponders Panmure bid
Latest EVG News
- Evgen notes evidence of radiosensitisation by SFX-01 in cancer cells
16 Mar 2023 - SUMMARY: London listings with exposure to Silicon Valley Bank
13 Mar 2023 - Evgen Pharma completes dosing of clinical trial for SFX-01 tablet
25 Jan 2023 - Evgen Pharma loss, operating expenses widen; SFX-01 study on schedule
8 Dec 2022 - Evgen Pharma starts clinical trial of new SFX-01 tablet
16 Nov 2022 - Evgen Pharma doses first volunteers in SFX-01 trial
16 Nov 2022 - CORRECT: Coral Products buys Ecodeck; Evgen Pharma recruits
13 Oct 2022 - TRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruits
12 Oct 2022
Related News
TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
TRADING UPDATES: Northcoders launches bootcamp; Schroder invests
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
EVG.L News
Evgen notes evidence of radiosensitisation by SFX-01 in cancer cells
(Alliance News) - Evgen Pharma PLC said on Thursday it had found further evidence of radiosensitisation by SFX-01 in sarcoma cells.
SUMMARY: London listings with exposure to Silicon Valley Bank
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separ...
Evgen Pharma completes dosing of clinical trial for SFX-01 tablet
(Alliance News) - Evgen Pharma PLC on Wednesday said it completed the dosing of all three cohorts of the phase 1/1b clinical trial of its SFX-01 table...
Evgen Pharma loss, operating expenses widen; SFX-01 study on schedule
(Alliance News) - Evgen Pharma PLC on Thursday said interim loss widened, but noted the healthy volunteer study of its SFX-01 formulation remains on s...
Evgen Pharma starts clinical trial of new SFX-01 tablet
(Alliance News) - Evgen Pharma PLC said on Wednesday it had started a randomised, placebo-controlled clinical trial of its new SFX-01 tablet.
Evgen Pharma doses first volunteers in SFX-01 trial
(Sharecast News) - Clinical-stage drug developer Evgen Pharma has dosed the first group of healthy volunteers in its placebo-controlled, dose-escalati...
CORRECT: Coral Products buys Ecodeck; Evgen Pharma recruits
(Correcting Harmony Energy Income Trust's use of funds.)
TRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruits
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Follow the stocks
